Publication Date
In 2025 | 5 |
Since 2024 | 10 |
Since 2021 (last 5 years) | 10 |
Since 2016 (last 10 years) | 10 |
Since 2006 (last 20 years) | 58 |
Descriptor
Stimulants | 59 |
Drug Therapy | 49 |
Attention Deficit… | 41 |
Outcomes of Treatment | 24 |
Symptoms (Individual… | 24 |
Attention Deficit Disorders | 19 |
Children | 16 |
Hyperactivity | 16 |
Correlation | 14 |
Adults | 12 |
Clinical Diagnosis | 11 |
More ▼ |
Source
Journal of Attention Disorders | 59 |
Author
Weyandt, Lisa L. | 6 |
Faraone, Stephen V. | 4 |
Advokat, Claire | 3 |
Arnold, L. Eugene | 3 |
Hinshaw, Stephen | 3 |
Vitiello, Benedetto | 3 |
Abikoff, Howard | 2 |
Benjamin Johnson | 2 |
Daniel Stjepanovic | 2 |
DuPaul, George J. | 2 |
Elliott, Glen | 2 |
More ▼ |
Publication Type
Journal Articles | 59 |
Reports - Research | 48 |
Information Analyses | 6 |
Reports - Evaluative | 6 |
Opinion Papers | 2 |
Education Level
Higher Education | 8 |
Elementary Secondary Education | 2 |
Postsecondary Education | 2 |
Elementary Education | 1 |
Grade 6 | 1 |
Audience
Location
New York | 2 |
Sweden | 2 |
Brazil | 1 |
California | 1 |
China | 1 |
Denmark | 1 |
France | 1 |
New York (New York) | 1 |
Norway | 1 |
Pennsylvania | 1 |
Virginia | 1 |
More ▼ |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Lenard A. Adler; Deepti Anbarasan; Taylor Sardoff; Terry Leon; Richard Gallagher; Caleb A. Massimi; Stephen V. Faraone – Journal of Attention Disorders, 2024
Objective: To examine the effects of triple beaded mixed amphetamine salts (TB MAS) on ADHD and executive dysfunction symptoms throughout the day in adults with DSM-5 ADHD. Method: This was a 6 week, single-blind, placebo-lead in trial of TB MAS (12.5-37.5 mg/day); all participants received 2 weeks of single-blind placebo); one individual was a…
Descriptors: Adults, Attention Deficit Hyperactivity Disorder, Drug Therapy, Executive Function
Brooke S. G. Molina; Heather M. Joseph; Heidi L. Kipp; Sarah L. Pedersen; David J. Kolko; Rachel A. Lindstrom; Daniel J. Bauer; Geetha A. Subramaniam – Journal of Attention Disorders, 2025
Objective: To test whether pediatrician training leads to provider utilization of stimulant diversion prevention strategies as reported by adolescent patients with ADHD. Methods: Pediatric practices received a stimulant diversion prevention workshop (SDP) or continued treatment-as-usual (TAU) in a cluster-randomized controlled trial. Surveys were…
Descriptors: Pediatrics, Physicians, Adolescents, Stimulants
Iliyan Ivanov; Beth Krone; Kurt Schulz; Riaz B. Shaik; Muhammad A. Parvaz; Jeffrey H. Newcorn – Journal of Attention Disorders, 2024
Background: Research examining the potential effects of stimulant exposure in childhood on subsequent development of substance use disorder (SUD) have focused on differences in the brain reward system as a function of risk. Methods: 18 drug naïve children ages 7 to 12 years (11 High Risk [ADHD + ODD/CD]; 7 Low Risk [ADHD only]), underwent fMRI…
Descriptors: Children, Attention Deficit Hyperactivity Disorder, Comorbidity, Drug Therapy
Craig B. H. Surman; Daniel M. Walsh; Joseph B. Bond – Journal of Attention Disorders, 2024
Objective: We appraised whether FDA registration trials for ADHD pharmacotherapy in adults provides comparable information to inform treatment expectations. Method: Comparison of ADHD outcome measure patterns in ADHD pharmacotherapy FDA drug label source studies. Results: Among stimulants, from fixed-dose titration data, amphetamine agents had…
Descriptors: Drug Therapy, Attention Deficit Hyperactivity Disorder, Adults, Stimulants
Benjamin Johnson; Daniel Stjepanovic; Janni Leung; Gary C. K. Chan – Journal of Attention Disorders, 2025
Background: The shortage of prescription stimulants is an ongoing issue that is impacting the ability of individuals with ADHD to access their medication. Amidst concerns that this shortage may have a substantial impact on individuals' ability to manage their symptoms effectively, this research seeks to understand the experiences and consequences…
Descriptors: Attention Deficit Hyperactivity Disorder, Drug Therapy, Stimulants, Access to Health Care
Yuwen Hung; Allison Green; Caroline Kelberman; Schuyler Gaillard; James Capella; Nicole Rudberg; John D. E. Gabrieli; Joseph Biederman; Mai Uchida – Journal of Attention Disorders, 2024
Objective: Stimulant medications are the main treatment for Attention Deficit Hyperactivity Disorder (ADHD), but overall treatment efficacy in adults has less than a 60% response rate. This study aimed to identify neural and cognitive markers predictive of longitudinal improvement in response to stimulant treatment in drug-naïve adults with ADHD.…
Descriptors: Stimulants, Drug Therapy, Attention Deficit Hyperactivity Disorder, Adults
Iris L. Rapoport; Annabeth P. Groenman – Journal of Attention Disorders, 2025
Objective: Stimulant medications are the primary pharmacological intervention for ADHD, yet our understanding of how sex and gender impact stimulant treatment outcomes remains limited. Clinical guidelines do not differ for female and male individuals despite possible sex and gender-related differences in effectiveness, adverse events, and…
Descriptors: Attention Deficit Hyperactivity Disorder, Gender Differences, Physiology, Stimulants
Frances R. Levin; John J. Mariani; Martina Pavlicova; C. Jean Choi; Cale Basaraba; Amy L. Mahony; Daniel J. Brooks; Christina A. Brezing; Nasir Naqvi – Journal of Attention Disorders, 2024
Objective: To determine if treatment of co-occurring adult ADHD and Cannabis Use Disorder (CUD) with extended-release mixed amphetamine salts (MAS-ER) would be effective at improving ADHD symptoms and promoting abstinence. Method: A 12-week randomized, double-blind, two-arm pilot feasibility trial of adults with comorbid ADHD and CUD (n = 28)…
Descriptors: Comorbidity, Attention Deficit Hyperactivity Disorder, Marijuana, Drug Abuse
Destin Groff; Wen-Jan Tuan; Kraig Holt; James R. Latronica; Curtis Bone – Journal of Attention Disorders, 2025
Introduction: Prescription stimulants are an effective FDA approved treatment for attention deficit hyperactivity disorder (ADHD) however their safety has come under scrutiny. Multiple studies demonstrate safe use in pediatric populations, but prescriptions are increasing to adults and it is not evident which comorbidities might place people at…
Descriptors: Heart Disorders, Stimulants, Attention Deficit Hyperactivity Disorder, Drug Therapy
Benjamin Johnson; Tianze Sun; Leo Wu; Stella Seal; Daniel Stjepanovic; Gary Chan; Janni Leung – Journal of Attention Disorders, 2025
Background: TikTok has become a significant influence on public health perceptions, especially regarding ADHD. With its expansive reach among younger demographics, TikTok content has the potential to shape public understanding and behaviors related to ADHD treatment. This study analyzed how prescription stimulants are depicted on TikTok to assess…
Descriptors: Social Media, Computer Mediated Communication, Attention Deficit Hyperactivity Disorder, Stimulants
Mattos, Paulo; Rodrigues Louza, Mario; Fernandes Palmini, Andre Luis; de Oliveira, Irismar Reis; Lopes Rocha, Fabio – Journal of Attention Disorders, 2013
The available literature provides few studies on the effectiveness of methylphenidate in improving quality of life in individuals with ADHD. Objective: To assess the effectiveness of Methyphenidate OROS formulation (OROS MPH) through QoL in adults with ADHD. Method: A 12-week, multicenter, open-label trial involving 60 patients was used. The…
Descriptors: Quality of Life, Drug Therapy, Attention Deficit Hyperactivity Disorder, Outcomes of Treatment
Niederhofer, Helmut – Journal of Attention Disorders, 2012
Objective: Antidepressants, in particular Atomextine, along with stimulants have demonstrated benefit in the treatment of ADHD. Agomelatine is a new antidepressant with additional affinities to the melatonergic system. As ADHD has been associated with sleep disorders, it is assumed that Agomelatiine might serve as a therapeutic alternative to…
Descriptors: Adolescents, Sleep, Attention Deficit Hyperactivity Disorder, Patients
Dussault, Crystal L.; Weyandt, Lisa L. – Journal of Attention Disorders, 2013
Objective: The objective of this study was to examine nonmedical stimulant use among fraternity/sorority members and nonmembers and whether psychological variables (e.g., internal restlessness, depression, anxiety, and stress) were related to nonmedical stimulant use. Method: The sample consisted of 1,033 undergraduate students from five…
Descriptors: Stimulants, Drug Abuse, Sororities, Fraternities
Faraone, Stephen V. – Journal of Attention Disorders, 2012
Objective: An earlier meta-analysis of pediatric clinical trials indicated that lisdexamfetamine dimesylate (LDX) had a greater effect size than other stimulant medications. This work tested the hypothesis that the apparent increased efficacy was artifactual. Method: The authors assessed two potential artifacts: an unusually high precision of…
Descriptors: Stimulants, Intervals, Effect Size, Drug Therapy
Fasmer, Ole Bernt; Riise, Trond; Eagan, Tomas Mikal; Lund, Anders; Dilsaver, Steven C.; Hundal, Oivind; Oedegaard, Ketil J. – Journal of Attention Disorders, 2011
Objective: To assess how frequently drugs used to treat asthma and ADHD are prescribed to the same patients. Method: The authors used data from the Norwegian Prescription Database for 2006, including the total Norwegian population (n = 4,640,219). Results: Anti-asthma drugs were prescribed to 350,894 persons (7.56 % of the population), anti-ADHD…
Descriptors: Diseases, Patients, Age Differences, Gender Differences